Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Carcinogenic Transcriptional Aberrations caused by Epigenomic Misregulation
EF 2018-19
Résumé
While the genetic information encoded in our DNA is stable, there is a layer of chemical modifications acting on the DNA's organization that can control transcription, or how genetic information is expressed, called the epigenome. The epigenome can be compared to a series of dimmer switches acting on the genome, "turning up", or "increasing transcription" of certain genes, or "turning down", or "repressing transcription" of genes, through different chemical modifications performed by epigenetic regulators either on the DNA itself or on histones, which are DNA-organizational units that package the DNA into structures called chromatin. Epigenetic malfunctions are often seen in certain cancers, and notably in multiple childhood cancers like pediatric glioblastoma or chondroblastoma. For this reason, understanding the effects of epigenetic dysregulation, like how it affects transcription and triggers aberrant transcription events, is key to understanding how these cancers begin and how to improve the efficacy of the treatment of these cancers. However, very little is known about how epigenetic dysregulation affects transcription, and whatever is known was based on unreliable experimental models. This project aims to improve this situation by using a bioinformatics-based approach to identify aberrant transcription initiation events occurring across the genome and understand the mechanism driving these events using a series of datasets obtained from appropriate models that better reflect what occurs in these cancers.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
415327
Name
Dancu Octavia M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Special Cases - Awards Programs
Projecttitle
Carcinogenic Transcriptional Aberrations caused by Epigenomic Misregulation
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer; Epigenetics; Epigenomics; Genomics; Head And Neck Cancer; Methylation; Mutation; Pediatric Glioblastoma; Transcription
Abstract
While the genetic information encoded in our DNA is stable, there is a layer of chemical modifications acting on the DNA's organization that can control transcription, or how genetic information is expressed, called the epigenome. The epigenome can be compared to a series of dimmer switches acting on the genome, "turning up", or "increasing transcription" of certain genes, or "turning down", or "repressing transcription" of genes, through different chemical modifications performed by epigenetic regulators either on the DNA itself or on histones, which are DNA-organizational units that package the DNA into structures called chromatin. Epigenetic malfunctions are often seen in certain cancers, and notably in multiple childhood cancers like pediatric glioblastoma or chondroblastoma. For this reason, understanding the effects of epigenetic dysregulation, like how it affects transcription and triggers aberrant transcription events, is key to understanding how these cancers begin and how to improve the efficacy of the treatment of these cancers. However, very little is known about how epigenetic dysregulation affects transcription, and whatever is known was based on unreliable experimental models. This project aims to improve this situation by using a bioinformatics-based approach to identify aberrant transcription initiation events occurring across the genome and understand the mechanism driving these events using a series of datasets obtained from appropriate models that better reflect what occurs in these cancers.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dancu, Octavia M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~